Feuerstein GZ* , Firestein R, Marcinkiewicz C.
Designation: FARMACON LLC, San Diego, California, USA
Citation: Feuerstein GZ, Firestein R, Marcinkiewicz C (2025) Development an Innovative, Contrarian and Unprecedented Theragnostic Technology based on Submicron Fluorescent Diamond Particles, FDP-NV-750NM Coated with Doxorubicin and Duplex Sorafenib. PART II: - In Vivo Proof of Hypotheses and Technical Feasibility for Direct to Tumor Injection of FDP-NV-DOX~SOR to Xenograft Tumors in Immune Compromised BALB/C2 ‘NUDE’ Mice. Int J Nano Rech Vol: 8, Issu: 1 (01-19).
Copyright: © 2025 Feuerstein GZ et al. This is an openaccess article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.